Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for April 2009
April 1, 2009
- FDA Acts to Halt Marketing of Certain Unapproved Prescription Narcotic Drugs
- FDA Sends Boehringer Ingelheim Roxane Inc. Warning Letter for Marketing Unapproved New Drugs Roxanol Oral Solution, 20 mg/ml and Roxicodone Tablets, 5 mg
- TorreyPines Therapeutics Reduces Workforce to Three Employees
- Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
- Appeals Court Affirms That J&J Stents Infringe Boston Scientific Patent; Claims Against TAXUS Liberte Dismissed
- Medical Leaders to Propose Curbs on Conflict of Interest
- Solvay Confirms It Is Proceeding With An Analysis Of Various Options For Its Pharmaceutical Activities
- Global Market For Pediatric Healthcare Worth $79.2 Billion In 2013
- Stanford Medical School to Provide Online Disclosure of Faculty's Consulting Activities
April 2, 2009
- Elan and Wyeth Plan to Amend Bapineuzumab Phase 3 Protocols
- Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL (lanthanum carbonate) Patents
- Astellas Appoints New US President and CEO
- Pfizer Discontinues One Sunitinib Phase 3 Trial in Advanced Breast Cancer; Other Advanced Breast Cancer Trials Continue
- Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
April 3, 2009
- Charles River to Acquire Piedmont Research Center
- PPD Acquires Magen BioSciences
- R&D Directions’ Data Management For Clinical Trials Webinar Details Data Capture And Management Strategies
- AstraZeneca's David Brennan Elected PhRMA Board Chairman
- Pfizer Receives Request for Additional Information from FTC Regarding Proposed Acquisition of Wyeth
- Pfizer Becomes The First Pharmaceutical Company To Be Accredited For Protection Of Human Rights In Clinical Research
April 6, 2009
- U.S. Appeals Court Issues Ruling in Support of Lilly in Ariad Patent Litigation
- Bristol-Myers Squibb Announces Extension of U.S. Agreement for Abilify and Establishment of an Oncology Collaboration with Otsuka
- Statement Regarding Possible Offer for Renovo
- FDA Sends Letters to 14 Companies Regarding Internet Ads
- CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
April 7, 2009
- Former Bristol-Myers Squibb Senior Executive Pleads Guilty for Role in Dishonest Dealings with the Federal Government
- Diabetes and Blood Pressure Medication Prescriptions Increase Among Children and Teens
- Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
- AstraZeneca Files Suit Against Apotex for a Declaratory Judgment of Infringement Against Pulmicort Respules Patents
- AMA Announces Staff Reductions
- 2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics
- Avalon Pharmaceuticals Receives Audit Opinion Containing Going Concern Statement
April 8, 2009
- Manhattan Research Releases Digital DTC Relevance Rankings, Revealing Which Condition Groups Are Most Likely to Adopt eHealth
- DDB Worldwide and M/A/R/C Research Find in Time of Economic Crisis: Health Is the New Wealth
- Mylan Announces Clarinex Settlement Agreement
- Governor, Legislature Support Sales Tax Exemptions For Clinical Trials and Free Samples of Drugs
- J. Michael Cook to Retire from Lilly Board of Directors
- Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market
April 9, 2009
- FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
- Inclusion of Untested Cancer Drug Clouds BC Government Announcement Recognizing Needs of Persons With Wet Age-Related Macular Degeneration
- Sanofi-aventis to Acquire Medley in Brazil
- New JHM Policies Tighten Rules on Industry Interactions
- Heartburn Medications do not Ease Asthma Symptoms
April 10, 2009
- Epocrates Alerts U.S. Physicians to Raptiva Recall Within Hours
- FDA Obtains Permanent Injunction Barring Two Companies from Manufacturing and Distributing Unapproved Drugs
April 13, 2009
- Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion
- RegeneRx Announces Financing Transaction and Cost Reduction Program
- PharmEng Announces Corporate Changes
- Pill-Splitting Program Cut Member Out-of-Pocket Costs by $1.7 Million
April 14, 2009
- Johnson & Johnson Reports 2009 First-Quarter Results
- Physicians "Get Smart" - Number of Docs Using Smartphones Surges to 64% in 2009
- SpePharm Announces a Claim in Excess of 35 Million Euros Against BioAlliance Pharma For Breaking up Their Joint-Venture SpeBio
April 15, 2009
- Sanofi-aventis to Acquire BiPar Sciences, a US Biopharmaceutical Company
- Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
- Gilead Sciences Successfully Completes Tender Offer for Shares of CV Therapeutics With Over 88 Percent of Shares Tendered
- Significant Growth in the Pharmaceutical Industry Drives China Into Global Spotlight, Finds New PricewaterhouseCoopers Report
- Roche and Genentech Announce Organizational and Leadership Decisions
April 16, 2009
- Baxter Announces Strong First Quarter Financial Results
- GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
- Biogen Idec Receives Approval for Tysabri High Titer Production
- Roche strongly outperforms market in first quarter
- Drug Marketing Disclosures Show Nearly $3 Million In Payments To Vermont Prescribers
- Infinity Halts RING Trial in Advanced Gastrointestinal Stromal Tumors
- PhRMA Statement on AARP Report
- Kalorama Anticipates Increase in Rx-to-OTC Switches as Result of Recession
- StemCells, Inc. Announces License Agreement with Major Pharmaceutical Company Covering Gene Insertion Technology
April 17, 2009
- Amylin Pharmaceuticals Reports First Quarter Financial Results
- Court Grants AstraZeneca Temporary Restraining Order Against Apotex in Pulmicort Respules Patent Litigation
- One in Eight Pharmaceutical Sales Visits Are Impossible to Achieve, Says New Report from ZS
- Discontinuation of Development of AC-3933, Therapeutic Agent for Dementia
- Chiltern Acquires Brazil-Based Clinical Research Organization Vigiun
- ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center
April 20, 2009
- GlaxoSmithKline and Stiefel to Create New World-leading Specialist Dermatology Business
- Lilly Reports Strong First-Quarter 2009 Results
- Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
April 21, 2009
- Schering-Plough Reports Financial Results for 2009 First Quarter
- Merck Announces First-Quarter 2009 Financial Results
- Healthline Launches Internet's First Treatment Search Tool; Healthline DocSearch Allows Consumers to Search; Compare and Connect to Relevant Specialists
- Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
- Boehringer Ingelheim Maintains its Growth Path in 2008
- Sanofi-Aventis Builds New Manufacturing Base in Hangzhou
- Sanofi-Aventis Announces New Investment in China to Locally Produce Lantus SoloSTAR
- Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
- Icahn Responds to Cook and Wilson
- Immtech to Reorganize Research and Development Operations
April 22, 2009
- Genzyme Reports Solid Financial Results for the First Quarter of 2009
- Discontinuation of Development of TAK-379 for Treatment of Diabetes
April 23, 2009
- Med Ad News Honors Healthcare Advertisers at 20th Annual Manny Awards
- Pharmaceuticals Delivers Strong Underlying Growth in First Quarter of 2009 as Novartis Continues to Rejuvenate Product Portfolio
- Updated FDA Action on Plan B (levonorgestrel) Tablets
- IMS Health Lowers 2009 Global Pharmaceutical Market Forecast to 2.5 – 3.5 Percent Growth
- Icahn Asks Amylin to Allow Discussions With Eastbourne
April 24, 2009
- Amylin Issues Statement in Response to Carl Icahn
- Amgen's First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08
- Sen. Grassley Works for Prescription Drug and Medical Device Safety
- Iressa (Gefitinib) Recommended for Approval for the Treatment of Non-Small Cell Lung Cancer in Europe
- Ad hoc: Jerini AG: Management Board and Supervisory Board Decide to Wind Down the Operations of Jerini Ophthalmic, Inc.
- Bristol-Myers Squibb and ZymoGenetics Present Positive 4-week Results of PEG-Interferon lambda with Ribavirin in Hepatitis C
- Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
- Eastbourne Capital Comments on Recent Developments Regarding Amylin Pharmaceuticals
- Regional Biotech Association Warns Legislation Would Make VT Least Friendly State in Nation for Biotechnology and Life Sciences
- Sucampo Acquires Rights to Rescula for U.S. and Canada
April 27, 2009
- Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion
- Biogen Idec Board Recommends Shareholders Elect Directors with Record of Success in Enhancing the Value of the Company
- SDI Reports Sixty-Seven Percent of Physicians Surveyed Have Positive Attitude Toward Electronic Promotional Activities
- Concerned Shareholders of Biovail Announce - Independent Nominees for Election to Biovail Board of Directors - A Focused Commitment to Governance at Biovail
April 28, 2009
- Bristol-Myers Squibb Reports Excellent First Quarter Financial Results; Delivers on Two Significant Strategic Initiatives
- Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors for the Treatment of Cancer
- Pfizer Reports First-Quarter 2009 Results; Reaffirms Full-Year 2009 Financial Guidance for Revenues and Adjusted Results
- Kyowa Hakko Kirin Fiscal 2008 Sales up 17.4%, Operating Income up 15.2%
- bioXell S.p.A (CH) - BioXell announces restructuring following review of portfolio
- FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans
- Pharmaceutical Industry Significantly Improves in Harris Interactive Reputation Study
- Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors
April 29, 2009
- PhRMA Applauds Kathleen Sebelius’ Confirmation as HHS Secretary
- Sanofi-aventis Announces Good First-quarter 2009 Performance
- Wyeth Reports Earnings Results for the 2009 First Quarter
- MRI Data Showing Tysabri Promoted Remyelination Presented at the 61st Annual Meeting of the American Academy of Neurology
- Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
- ZymoGenetics Announces Workforce Reduction and Restructuring
- Statement from Roche Canada re: Supply of Tamiflu (oseltamivir)
- Rx Response Raised to 'Alert Status' in Response to Growing Swine Flu Threat
April 30, 2009
- Interim financial report for the period 1 January 2009 to 31 March 2009 (30 April 2009)
- AstraZeneca PLC First Quarter Results 2009
- Shire Begins the Year with a Strong Performance
- FDA MedWatch - Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B): Strengthened warnings in product labeling
- Pharmaceutical Companies Are Looking to Reshape the Multi-Billion Dollar Drug Industry, Says New PricewaterhouseCoopers Report
- FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill
- Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of Dysport
